CC
REPL icon

Centiva Capital’s Replimune Group REPL Stock Holding History

Centiva Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-248,800
Closed -$1.04M – 1543
2025
Q3 		$1.04M Buy
248,800
+98,800
+66% +$631K 0.01% 484
2025
Q2 		$1.39M Buy
+150,000
New +$1.31M 0.02% 474

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Centiva Capital's REPL Position: Q1 2026 in Review

Centiva Capital held its Replimune Group (REPL) position steady in Q1 2026 at 18,000 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Centiva Capital first reported a position in REPL in Q2 2024 and has held it in 4 quarters since. The position peaked at $690K in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Centiva Capital held 18,000 shares of Replimune Group worth $138K as of Q1 2026.
  • Centiva Capital left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1345 holding.
  • Centiva Capital first reported a position in Replimune Group in Q2 2024 and has held it in 4 quarters since.
  • Centiva Capital's Replimune Group position peaked at $690K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.